Loreal, FR0000120321

L'Oreal stock sits below EUR 407.40 ahead of October 22 sales

Published on 10/21/2026 at 09:07 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
L'Oreal reports nine-month sales on October 22, 2026 after revenue rose 5.80 percent. L'Oreal stock costs EUR 403.08 on October 21, 2026 versus EUR 403.60.

Sales date and growth context

  • L'Oreal's nine-month sales update is scheduled for October 22, 2026.
  • First-half 2026 revenue rose 5.80 percent to EUR 23.80 billion.
  • L'Oreal stock trades at EUR 403.08 at 9:05 a.m. CEST at Lang & Schwarz on October 21, 2026, 0.13 percent below the Xetra close of October 20, 2026.
  • A target was raised from EUR 340.00 to EUR 350.00 on October 20, 2026.
L'Oréal S.A. (FR0000120321) betreibt moderne Labore zur Entwicklung hochwertiger Hautpflege- und Kosmetikprodukte, Illustration mit AI erstellt.

L'Oreal (ISIN FR0000120321) was trading at EUR 403.08 in Lang & Schwarz pre-market trading on October 21, 2026 at 9:05 a.m. CEST, 0.13 percent below the Xetra close of October 20, 2026 at EUR 403.60. The company is due to publish nine-month sales on October 22, 2026, according to L'Oreal Finance.

Three milestones shape the setup

L'Oreal announced a majority investment in Indian beauty group Innovist on June 18, 2026, then disclosed a 50-year global Gucci beauty license with Kering on July 7, 2026, according to L'Oreal Finance. On October 22, 2026, the company is scheduled to release sales for the nine months through September.

The sequence gives investors a clear near-term test: whether the sales update can support the growth rate already reported for the first half. The upcoming figure matters because the stock is only EUR 4.32 below its 52-week high of EUR 407.40.

What does first-half growth mean?

First-half 2026 revenue reached EUR 23.80 billion, up 5.80 percent from the first half of 2025, while net income rose 5.30 percent to EUR 3.55 billion, according to Simply Wall St. The comparison puts the October sales release in context: a similar pace would reinforce the operating trend, while a weaker figure would challenge the premium valuation signaled by the share price.

Analyst target moves higher

On October 20, 2026, L'Oreal's target was raised from EUR 340.00 to EUR 350.00, while the negative recommendation remained in place, Goldesel reported. The new target is EUR 53.08 below the Lang & Schwarz price, highlighting the gap between the quoted market level and that analyst view.

Dates investors can track

The next scheduled company event is the nine-month sales release on October 22, 2026. L'Oreal's next earnings report is listed for February 11, 2027, by TradingView.

Stock remains below its yearly high

The current euro quote sits 1.06 percent below the 52-week high of EUR 407.40, leaving the sales release as the next concrete test of the valuation. The share was trading at EUR 403.08 at Lang & Schwarz on October 21, 2026 at 9:05 a.m. CEST, 0.13 percent below the Xetra close of October 20, 2026 at EUR 403.60. The further course of trading is shown by the continuously updated real-time quote of L'Oreal stock.

L'Oreal stock facts

  • Company: L'Oreal S.A.
  • ISIN: FR0000120321
  • Ticker: OR.PA
  • Price Lang & Schwarz (as of October 21, 2026, 9:05 a.m. CEST): EUR 403.08
  • Change versus Xetra close: minus 0.13 percent
  • Xetra close (October 20, 2026): EUR 403.60
  • Market capitalization: EUR 215.2 billion (as of October 20, 2026)
  • 52-week range: EUR 338.85-EUR 407.40 (as of October 20, 2026)
  • Sector / Industry: Consumer Defensive / Household and Personal Products

Market context: Market report CAC 40.

More news and analyses on L'Oreal stock

Disclaimer...
en | FR0000120321 | LOREAL | boerse | 70380587 | bgmi